Status | Study |
Not yet recruiting |
Study Name: Giant Cell Arteritis: Improving Use of Ultrasound Evaluation Condition: Giant Cell Arteritis Date: 2015-08-04 Interventions: Device: Ultrasound of temporal and axillary arteries Each patient will have a clinical assessment and ul |
Recruiting |
Study Name: Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis Condition: Giant Cell Arteritis Date: 2015-07-06 Interventions: Drug: Sirukumab Sirukumab will |
Terminated |
Study Name: Study of the T CD8 Immune Response in Horton's Disease Condition: Horton's Disease Date: 2014-03-05 Interventions: Other: Blood sample drawn into a 5 mL dry tube at the diagnosis and after 3 |
Terminated |
Study Name: A Study Assessing the Efficacy and Safety of Lodotra® Compared to Prednisone IR in Subjects Suffering From PMR Condition: Polymyalgia Rheumatica Date: 2013-03-14 Interventions: Drug: Lodotra® Lodotra, s |
Completed |
Study Name: Tocilizumab Effect iN pOlymyalgia Rheumatica Condition: Polymyalgia Rheumatica Date: 2012-09-17 Interventions: Drug: TCZ Tocilizumab at week 0, 4 and 8. |
Completed |
Study Name: Tocilizumab for Patients With Giant Cell Arteritis Condition: Giant Cell Arteritis Date: 2011-10-03 Interventions: Drug: Tocilizumab + Glucocorticoids (GCs) |
Completed |
Study Name: Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis Condition: Giant Cell Arteritis Date: 2011-07-21 Interventions: Drug: Prednisone therapy and pharmacokinetic Prednisone therapy delivered in accordance with a 10 to 18 |
Completed |
Study Name: Infliximab Therapy in Patients With Refractory Polymyalgia Rheumatica Condition: Polymyalgia Rheumatica Date: 2011-07-19 Interventions: Drug: infliximab Infliximab 5 |
Completed |
Study Name: Study of Tocilizumab to Treat Polymyalgia Rheumatica Condition: Polymyalgia Rheumatica (PMR) Date: 2011-07-11 Interventions: Drug: Tocilizumab Tocilizumab is a humanized anti-interleukin-6 receptor antibody that has been FDA appr |
Terminated |
Study Name: A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica Condition: Polymyalgia Rheumatica Inflammatory Diseases Date: 2011-03-10 Interventions: Drug: AIN457 3 mg/kg |